Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·What a three-way study of sleep, exercise, and dementia risk can show
Clinical TrialA registered study compares sleep support, exercise, and both over 12 weeks. Its protocol describes planned measurements, not demonstrated dementia prevention.
-
Evidence date ·How cells that stop dividing might connect aging to severe COVID-19
Review or Meta-AnalysisA 2021 review connects immune aging, senescent-cell signals and ACE2’s two roles, then weighs how far evidence from other viruses can support treatment ideas.
-
Evidence date ·When the sound around a person with dementia becomes part of care
Clinical TrialA 2021 trial registration proposes personalized soundscapes for dementia care, measuring distress, sleep, stress and quality of life without claiming results.
-
Evidence date ·Can caregivers stick with a self-administered hypnosis program?
Clinical TrialA 2021 registry describes proposed randomized feasibility research comparing self-administered hypnosis with sham white noise hypnosis and planned caregiver sleep measures.
-
Evidence date ·A pilot asks whether clearing senescent cells could improve walking after childhood cancer
Clinical TrialA 2021 registry pilot pairs two short treatments intended to clear senescent cells with walking-speed and blood-marker checks at days 60 and 150.
-
Evidence date ·Aging immunity may need new cells and healthy support tissues
Review or Meta-AnalysisAn August 2025 review links declining T-cell renewal to thymus and lymph-node changes and asks how treatment findings translate to ordinary aging.
-
Evidence date ·How aging biology may shape physical and cognitive function after cancer
Review or Meta-AnalysisA 2021 review connects aging biology, nutrition, and functional measures to cancer survivorship research—without promising a ready treatment.
-
Evidence date ·Four weeks of supplementation revealed different brain creatine responses
Clinical TrialIn 19 healthy men given guanidinoacetic acid for four weeks, brain creatine rose in some locations and fell in another. No functional benefit was established.
-
Evidence date ·How aging changes the heart’s blood supply and complicates treatment choices
Review or Meta-AnalysisA 2026 review connects heart aging to vessel stiffening, cellular stress and repair tradeoffs while separating clinical studies from proven patient benefit.
-
Evidence date ·Could targeting aging cells protect the Parkinson’s brain?
Review or Meta-AnalysisA 2026 review traces how aging immune cells may worsen Parkinson’s inflammation and compares clearing senescent cells with quieting their signals.